406 related articles for article (PubMed ID: 15222978)
21. Anti-inflammatory activities of ent-16alphaH,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation.
Park HJ; Kim IT; Won JH; Jeong SH; Park EY; Nam JH; Choi J; Lee KT
Eur J Pharmacol; 2007 Mar; 558(1-3):185-93. PubMed ID: 17207792
[TBL] [Abstract][Full Text] [Related]
22. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.
De Ridder M; Verovski VN; Darville MI; Van Den Berge DL; Monsaert C; Eizirik DL; Storme GA
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):598-606. PubMed ID: 15380597
[TBL] [Abstract][Full Text] [Related]
23. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
[TBL] [Abstract][Full Text] [Related]
24. Janus kinase 3 inhibitor WHI-P154 in macrophages activated by bacterial endotoxin: differential effects on the expression of iNOS, COX-2 and TNF-alpha.
Sareila O; Korhonen R; Kärpänniemi O; Nieminen R; Kankaanranta H; Moilanen E
Int Immunopharmacol; 2008 Jan; 8(1):100-8. PubMed ID: 18068105
[TBL] [Abstract][Full Text] [Related]
25. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.
Vila-del Sol V; Díaz-Muñoz MD; Fresno M
J Leukoc Biol; 2007 Jan; 81(1):272-83. PubMed ID: 17035338
[TBL] [Abstract][Full Text] [Related]
26. Gigantol isolated from the whole plants of Cymbidium goeringii inhibits the LPS-induced iNOS and COX-2 expression via NF-kappaB inactivation in RAW 264.7 macrophages cells.
Won JH; Kim JY; Yun KJ; Lee JH; Back NI; Chung HG; Chung SA; Jeong TS; Choi MS; Lee KT
Planta Med; 2006 Oct; 72(13):1181-7. PubMed ID: 16924582
[TBL] [Abstract][Full Text] [Related]
27. Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells.
Mi Jeong Sung ; Davaatseren M; Kim W; Sung Kwang Park ; Kim SH; Haeng Jeon Hur ; Myung Sunny Kim ; Kim YS; Dae Young Kwon
Int Immunopharmacol; 2009 Mar; 9(3):319-23. PubMed ID: 19135555
[TBL] [Abstract][Full Text] [Related]
28. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells.
Bae IK; Min HY; Han AR; Seo EK; Lee SK
Eur J Pharmacol; 2005 Apr; 513(3):237-42. PubMed ID: 15862806
[TBL] [Abstract][Full Text] [Related]
29. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo.
Shiratori K; Ohgami K; Ilieva I; Jin XH; Koyama Y; Miyashita K; Yoshida K; Kase S; Ohno S
Exp Eye Res; 2005 Oct; 81(4):422-8. PubMed ID: 15950219
[TBL] [Abstract][Full Text] [Related]
30. Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93.
Holzknecht C; Röhl C
Neuroimmunomodulation; 2010; 17(1):23-30. PubMed ID: 19816054
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
32. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways.
Choi HJ; Eun JS; Park YR; Kim DK; Li R; Moon WS; Park JM; Kim HS; Cho NP; Cho SD; Soh Y
Eur J Pharmacol; 2008 Dec; 601(1-3):171-8. PubMed ID: 18929556
[TBL] [Abstract][Full Text] [Related]
33. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-kappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages.
Jung CH; Kim JH; Hong MH; Seog HM; Oh SH; Lee PJ; Kim GJ; Kim HM; Um JY; Ko SG
J Ethnopharmacol; 2007 Apr; 110(3):490-7. PubMed ID: 17112694
[TBL] [Abstract][Full Text] [Related]
34. Pentoxifylline downregulates nitric oxide and tumor necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.
Park E; Schuller-Levis G; Park SY; Jia JH; Levis WR
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):225-33. PubMed ID: 11875767
[TBL] [Abstract][Full Text] [Related]
35. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells.
Kim JH; Kim DH; Baek SH; Lee HJ; Kim MR; Kwon HJ; Lee CH
Biochem Pharmacol; 2006 Apr; 71(8):1198-205. PubMed ID: 16457781
[TBL] [Abstract][Full Text] [Related]
36. Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells.
Pan CH; Kim ES; Jung SH; Nho CW; Lee JK
Arch Pharm Res; 2008 Nov; 31(11):1447-56. PubMed ID: 19023541
[TBL] [Abstract][Full Text] [Related]
37. The enhancing action of D-galactosamine on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells.
Morikawa A; Koide N; Sugiyama T; Mu MM; Hassan F; Islam S; Ito H; Mori I; Yoshida T; Yokochi T
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):211-8. PubMed ID: 15196570
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism of endothelial nitric-oxide synthase activation by Platycodon grandiflorum root-derived saponins.
Kim HG; Hien TT; Han EH; Chung YC; Jeong HG
Toxicol Lett; 2010 Jun; 195(2-3):106-13. PubMed ID: 20230881
[TBL] [Abstract][Full Text] [Related]
39. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells.
Yoon HJ; Moon ME; Park HS; Im SY; Kim YH
Biochem Biophys Res Commun; 2007 Jul; 358(3):954-9. PubMed ID: 17512902
[TBL] [Abstract][Full Text] [Related]
40. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V
J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
